TYRO3 and gastric cancer: In summary, our current study emphasized that high TYRO3 expression significantly correlated with clinical metastasis and poor prognoses in patients with GC, and TYRO3 promoted cell growth, invasion, and metastasis via activation of the Wnt/β-catenin signaling-mediated EMT, thus possibly providing a potential therapeutic target for GC.